SCHEMBL9942701

SCHEMBL9942701

Cc1cccc(-c2cn3c(-c4ccc(C(N)=O)c(C5CC5)c4)cnc3c(NCC(C)C)n2)c1C

nearest known ligand 0.51

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TTK P33981 20/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9942689 0.94 TTK (0.53) TTK
SCHEMBL9942170 0.90 TTK (0.54) TTK
SCHEMBL9942208 0.90 TTK (0.56) TTK
SCHEMBL9942746 0.89 TTK (0.52) TTK
SCHEMBL9942692 0.88 TTK (0.52) TTK
SCHEMBL9942749 0.88 TTK (0.55) TTK
SCHEMBL9942731 0.88 TTK (0.56) TTK
SCHEMBL9942206 0.88 TTK (0.51) TTK
SCHEMBL9942697 0.87 TTK (0.54) TTK
SCHEMBL9942729 0.87 TTK (0.53) TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651950-A1 6 SUBSTITUTED IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS Bayer Intellectual Property GmbH (DE) 2013-10-23 EP claimed
WO-2012080230-A1 6 SUBSTITUTED IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-06-21 WO claimed